Introduction
Regulations permitting an exception from informed consent have facilitated an increasing number of pivotal clinical trials across a range of emergency cardiovascular, neurologic, and traumatic conditions. Although experience and comfort with exception from informed consent has increased among investigators, institutional review boards, and regulators, the requirement that investigators consult communities before approval and initiation of a proposed trial continues to pose challenges.1, 2 This is not surprising, especially because community consultation is not required by regulation for any other form of research.2, 3Editor’s Capsule Summary
What is already known on this topic
An increasing number of studies in the emergency department setting involve exception from informed consent.
What question this study addressed
How do investigators measure community acceptance of exception from informed consent research?
What this study adds to our knowledge
Community acceptance rates vary widely and are difficult to interpret because the process of involving communities and gauging their support of exception from informed consent research is underdeveloped.
How this is relevant to clinical practice
As we strive toward more patient-centered care, we must learn how to successfully engage and attain community support for research on the care of urgently ill patients.
Food and Drug Administration guidance enumerates 4 principal goals of community consultation: (1) to show respect for persons by informing the community in advance; (2) to inform community members in advance and facilitate meaningful input to the institutional review board; (3) to show respect for the community through allowing community members to identify potential concerns; and (4) to show respect for autonomy, particularly by inclusion of individuals expected to be similar to enrolled subjects.3 Other proposed goals in the literature include fostering trust and sharing responsibility with the community.3, 4, 5, 6 Although these goals are laudable, putting them into operation and prioritizing among them has been challenging.
One problem has been to ascertain the proper role of community consultation feedback in approval decisions. Food and Drug Administration guidance explicitly distinguishes community consultation from community consent, and the regulations do not require quantifying community acceptance.3 However, quantitatively assessing community acceptance has been a focus of many consultation efforts, and analogies have been drawn between community consultation and democratic decisionmaking.7 Knowing what to do with acceptance data can be difficult for investigators and institutional review boards, and it is unknown how many studies have been altered or disapproved in accordance with community consultation feedback. One investigator described a decision not to pursue a trial of a blood substitute study after community consultation alerted the team to the high local prevalence of Jehovah’s Witnesses.8 However, a survey of institutional review board chairs at US medical schools reported no rejections of exception from informed consent trials because of unfavorable community feedback.9 No consensus exists about what levels of disagreement are problematic.
In addition to questions about appropriate levels of acceptance, interpreting acceptance data is made more challenging by the existence of highly divergent consultation practices striking different balances between population representation and interaction with consultants. These methods range from detailed interviews with stakeholders to large population-based surveys. These methods prioritize different goals, facilitate different kinds of feedback, and appear to affect consultants’ attitudes toward proposed exception from informed consent trials.10, 11, 12
A body of literature has emerged reporting the results of community consultation for exception from informed consent research since passage of the exception from informed consent regulations in 1996. Acceptance data are the focus of many of these reports. We conducted a systematic review of this literature to clarify reported ranges of acceptance, identify potential predictors of acceptance, and clarify areas for further study. A major goal was to identify trends that may aid investigators and institutional review boards in designing consultation efforts and interpreting their results.